The researchers, led by Elizabeth Loboa, PhD, Columbia-based University of Missouri College of Engineering’s dean and a bioengineering professor, coated the threads of a bone-forming scaffold with a silver ion-containing solution before testing.
Sign up for our FREE E-Weekly for more coverage like this sent to your inbox
They found that seeding the right amount of silver into a biodegradable scaffold alongside bone-generating stem cells inhibits the growth of or kills MRSA while still forming bone.
“The silver ions go in and completely disrupt the MRSA cell machinery, and they can inhibit growth and kill the bacteria,” Dr. Loboa said. “It’s a fine line. If you overuse too much of the silver, it’s bad for the mammalian cells. We want to make sure we don’t hurt our host cells but kill the bacterial cells.”
Tissue Engineering, Part A recently published the research team’s findings.
More articles on healthcare quality:
Nearly half of HIV-positive blacks do not receive regular medical treatment
Routinely prescribed antibiotic may not be best severe C. diff treatment
Mothers who deliver preterm infants at higher risk for heart disease later in life
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.